Reading IREN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IREN free→Reading IREN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IREN free→QuarterlyIQ Insights · IREN
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $43.01. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $79.00 | — | — | Analyst | low |
| graham number | 12M | $9.22 | — | — | TTM | low |
| Peer P/B | 12M | $20.61 | 2.6 | 7.98 | TTM | low |
| Peer P/E | 12M | $11.19 | 23.6 | 0.47 | TTM | low |
| Peer P/S | 12M |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| $6.90 |
| 3.0 |
| 2.27 |
| TTM |
| low |
| residual income | 12M | $7.17 | — | — | TTM | low |